Cadre Holdings, Inc. Revenue
Cadre Holdings, Inc. (CDRE) reported Revenue of $207.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-05
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $207.13M, a 31.84% increase year-over-year.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $155.43M, a 19.46% increase year-over-year.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $167.22M, a 4.98% decline year-over-year.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $155.87M, a 42.47% increase year-over-year.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $610.31M, a 7.53% increase from fiscal 2024.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $567.56M, a 17.62% increase from fiscal 2023.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $482.53M, a 5.39% increase from fiscal 2022.
- Cadre Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $457.84M, a 7.15% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $207.13M 10-Q · filed 2026-08-05 | $362.56M 10-Q · filed 2026-08-05 | $529.78M derived: sum of 3 quarters · filed 2026-08-05 | $685.65M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $155.43M 10-Q · filed 2026-05-11 | $322.65M derived: sum of 2 quarters · filed 2026-05-11 | $478.52M derived: sum of 3 quarters · filed 2026-05-11 | $635.63M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $167.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $323.09M derived: sum of 2 quarters · filed 2026-03-10 | $480.20M derived: sum of 3 quarters · filed 2026-08-05 | $610.31M 10-K · filed 2026-03-10 |
| 2025-09-30 | $155.87M 10-Q · filed 2025-11-04 | $312.98M derived: sum of 2 quarters · filed 2026-08-05 | $443.08M 10-Q · filed 2025-11-04 | $619.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $157.11M 10-Q · filed 2026-08-05 | $287.21M 10-Q · filed 2026-08-05 | $463.20M derived: sum of 3 quarters · filed 2026-08-05 | $572.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $130.11M 10-Q · filed 2026-05-11 | $306.09M derived: sum of 2 quarters · filed 2026-05-11 | $415.50M derived: sum of 3 quarters · filed 2026-05-11 | $559.81M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $175.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $285.39M derived: sum of 2 quarters · filed 2026-03-10 | $429.70M derived: sum of 3 quarters · filed 2026-03-10 | $567.56M 10-K · filed 2026-03-10 |
| 2024-09-30 | $109.41M 10-Q · filed 2025-11-04 | $253.72M derived: sum of 2 quarters · filed 2025-11-04 | $391.58M 10-Q · filed 2025-11-04 | $516.16M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $144.31M 10-Q · filed 2025-08-05 | $282.17M 10-Q · filed 2025-08-05 | $406.75M derived: sum of 3 quarters · filed 2026-03-10 | $531.87M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $137.86M 10-Q · filed 2025-05-06 | $262.44M derived: sum of 2 quarters · filed 2026-03-10 | $387.56M derived: sum of 3 quarters · filed 2026-03-10 | $508.64M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $124.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $249.70M derived: sum of 2 quarters · filed 2026-03-10 | $370.78M derived: sum of 3 quarters · filed 2026-03-10 | $482.53M 10-K · filed 2026-03-10 |
| 2023-09-30 | $125.11M 10-Q · filed 2024-11-06 | $246.20M derived: sum of 2 quarters · filed 2024-11-06 | $357.95M 10-Q · filed 2024-11-06 | $481.59M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $121.09M 10-Q · filed 2024-08-09 | $232.84M 10-Q · filed 2024-08-09 | $356.48M derived: sum of 3 quarters · filed 2025-03-11 | $468.03M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $111.75M 10-Q · filed 2024-05-08 | $235.39M derived: sum of 2 quarters · filed 2025-03-11 | $346.95M derived: sum of 3 quarters · filed 2025-03-11 | $465.18M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $123.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $235.20M derived: sum of 2 quarters · filed 2025-03-11 | $353.43M derived: sum of 3 quarters · filed 2025-03-11 | $457.84M 10-K · filed 2025-03-11 |
| 2022-09-30 | $111.55M 10-Q · filed 2023-11-08 | $229.79M derived: sum of 2 quarters · filed 2023-11-08 | $334.19M 10-Q · filed 2023-11-08 | $437.73M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $118.23M 10-Q · filed 2023-08-08 | $222.64M 10-Q · filed 2023-08-08 | $326.18M derived: sum of 3 quarters · filed 2024-03-12 | $424.83M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | $104.41M 10-Q · filed 2023-05-09 | $207.94M derived: sum of 2 quarters · filed 2024-03-12 | $306.60M derived: sum of 3 quarters · filed 2024-03-12 | $421.16M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $103.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $202.19M derived: sum of 2 quarters · filed 2024-03-12 | $316.75M derived: sum of 3 quarters · filed 2024-03-12 | $427.29M 10-K · filed 2024-03-12 |
| 2021-09-30 | $98.65M 10-Q · filed 2022-11-10 | $213.22M derived: sum of 2 quarters · filed 2022-11-10 | $323.75M 10-Q · filed 2022-11-10 | $431.37M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $114.56M 10-Q · filed 2022-08-11 | $225.10M 10-Q · filed 2022-08-11 | $332.72M derived: sum of 3 quarters · filed 2022-08-11 | $438.45M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $110.54M 10-Q · filed 2022-05-16 | $218.16M derived: sum of 2 quarters · filed 2022-05-16 | $323.89M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $107.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $213.36M derived: sum of 2 quarters · filed 2022-03-11 | $404.64M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $105.73M 10-Q · filed 2021-12-02 | $297.02M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |